• Recruiting

NCT04221178: Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission

NCT04221178: Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission

mrd negative myeloma

NCT04221178: Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission


This study will test whether stopping maintenance therapy in people with multiple myeloma in MRD-negative remission has the same effect on disease control as continuing this therapy. The study will look at whether people currently on maintenance therapy can safely stop this treatment and continue with active surveillance instead while keeping their MRD-negative remission status for at least 1 year.


Sponsor

Memorial Sloan Kettering Cancer Center

 

ClinicalTrials.gov Identifier: NCT04221178

Official Title: A Single-Arm, Prospective Study of Maintenance Therapy Cessation for Patients With Multiple Myeloma in Sustained MRD-Negative Remissions

First Posted : January 9, 2020

Click here for details on ClinicalTrials.gov

 

Other: Cessation of continuous maintenance therapy

 

- New York: Memorial Sloan-Kettering Cancer Center New York

 

Location

United States, New Jersey

United States, New York




Posts Archive